On Nov 8, 2021 GeneCentric Therapeutics closed a Series B round and raised $7,500,000 from Alexandria Venture Investments, Hatteras Venture Partners, IAG Capital Partners, LabCorp, […]
Series A – DeepCure
On Nov 8, 2021 DeepCure closed a Series A round and raised $40,000,000 from Benon Group Ltd., Morningside Ventures, Sapir Venture Partners, TLV Partners, featuring […]
Series A – Beacon Biosignals
On Nov 8, 2021 Beacon Biosignals closed a Series A round and raised $27,000,000 from Andrew Beck, Casdin Capital, General Catalyst, featuring lead investors General […]
Series A – Marengo Therapeutics
On Nov 8, 2021 Marengo Therapeutics closed a Series A round and raised $80,000,000 from Apple Tree Partners, featuring lead investors Apple Tree Partners. About […]
Series B – Platelet BioGenesis
On Nov 4, 2021 Platelet BioGenesis closed a Series B round and raised $75,500,000 from K2 HealthVentures, Oxford Finance LLC, Qiming Venture Partners, SymBiosis LLC, […]
Series A – Cellenkos
On Nov 4, 2021 Cellenkos closed a Series A round and raised $15,000,000 from BVCF, featuring lead investors BVCF. About the company: Cellenkos is located […]
Series B – Molecular Assemblies
On Nov 4, 2021 Molecular Assemblies closed a Series B round and raised $10,000,000 from SynBio Innovation Accelerator, featuring lead investors SynBio Innovation Accelerator. About […]
Series B – Neuro-ID
On Nov 4, 2021 Neuro-ID closed a Series B round and raised $35,000,000 from Canapi Ventures, Fin Venture Capital, TTV Capital, featuring lead investors Canapi […]
Series A – Primmune Therapeutics
On Nov 4, 2021 Primmune Therapeutics closed a Series A round and raised $8,400,000 from investors, featuring lead investors . About the company: Primmune Therapeutics […]
Series B – Molecular Assemblies
On Nov 4, 2021 Molecular Assemblies closed a Series B round and raised $10,000,000 from SynBio Innovation Accelerator, featuring lead investors SynBio Innovation Accelerator. About […]
